Form 8-K - Current report:
SEC Accession No. 0001564590-21-019230
Filing Date
2021-04-19
Accepted
2021-04-16 19:02:27
Documents
12
Period of Report
2021-04-16
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K rcus-8k_20210416.htm   iXBRL 8-K 30689
  Complete submission text file 0001564590-21-019230.txt   155630

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rcus-20210416.xsd EX-101.SCH 5776
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rcus-20210416_lab.xml EX-101.LAB 18719
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rcus-20210416_pre.xml EX-101.PRE 11175
5 EXTRACTED XBRL INSTANCE DOCUMENT rcus-8k_20210416_htm.xml XML 3419
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

EIN.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38419 | Film No.: 21832680
SIC: 2834 Pharmaceutical Preparations